Back to SNDX

Elmind Capital, LP → SNDX

Elmind Capital, LP SNDX Position History

Syndax Pharmaceuticals, Inc. • Healthcare

Quarters held
4
Latest value
$30.2M
Q3 2026
Peak value
$43.3M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$39M
Q1 2026$43.3M
Q2 2026$40.6M
Q3 2026$30.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$30.2M1.60M——
Q2 2026$40.6M1.85M——
Q1 2026$43.3M1.85M——
Q4 2025$39M1.85M——

Other funds holding SNDX

Other Elmind Capital, LP positions

COGT

COGENT BIOSCIENCES INC

$45.3M
COGT

COGENT BIOSCIENCES INC

$45.1M
COGT

COGENT BIOSCIENCES INC

$41.6M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36.8M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36M
LEGN

LEGEND BIOTECH CORP

$31.2M
COGT

COGENT BIOSCIENCES INC

$27.8M
CLDX

CELLDEX THERAPEUTICS INC NEW

$27.4M